Antimicrobial Agents and Chemotherapy · 2001 · 43 citations · 15 references
PharmacyPharmacologyPharmacotherapyAntimicrobial PharmacologyAntimicrobial PharmacotherapyAntimicrobial ResistanceAntibacterial PharmacotherapyAntibacterial TherapyAntibiotic ResistanceAntimicrobial TherapyBacterial InfectionsCombination Antimicrobial TherapyEnterococcal BacteremiaEnterococcal Infection TreatmentEnterococcal InfectionsEnterococciEnterococcus ResistanceMinocycline TherapyVancomycin-resistant Enterococcal InfectionVancomycin-resistant Enterococci
Between February 1994 and November 1998, 56 oncology patients infected with vancomycin-resistant enterococci (VRE) were treated with quinopristin-dalfopristin (Q-D) plus minocycline (MIN). Infections included bacteremia, urinary tract infection, pneumonia, and wound infection. The response rate was 68%, and the most frequent adverse event was arthralgia or myalgia (36%). Q-D-MIN is effective for VRE infection in cancer patients but is associated with a substantial frequency of arthralgia or myalgia.
15
William A. Knaus, Elizabeth A. Draper, Douglas P. Wagner et al. · Critical Care Medicine · 1985 · 13.7K citations
Medicine, Internal Medicine, Clinical Classification Systems +16
APACHE II: a severity of disease classification system.
Elizabeth S. Draper · PubMed · 1985 · 6.1K citations